This strategic relationship is expected to support company’s preparation for an investigational new drug application for Homspera. Efforts to be pursued at Lovelace will involve both the inhalational
Qscan-Clinical will include a database of marketed drug label data to assist in comparator study design and data analysis. Clients already using Qscan-ERM with their proprietary post-market safety
The Australian Register of Therapeutic Goods communicated its decision to approve the registration submitted by licensee Solvay Biosciences of Zan-Extra in its two dosage forms containing lercanidipine 10mg/enalapril
The patent-protected gene sequences have been tested as HIV vaccine candidates on 40 test persons by the EuroVacc Foundation in a Phase I clinical trial. In the trial,
Rami Eliakim, director of the Department of Gastroenterology at Rambam Medical Center, Haifa, Israel, said: “PillCam Colon offers a non-invasive alternative for individuals who cannot or do not
The aggregate gross proceeds from the common stock offering and the note offering, before commissions and expenses, are approximately $405.8 million.
The agreements between Novavax and Graceway provide for the sale of the patent associated with the product, the sale of other intellectual properties and assets, and the sale
The transaction, which is subject to customary closing conditions, is expected to be completed in the second calendar quarter of 2008.
The study is part of a collaborative research and license agreement between Lipid Sciences and Elanco to research immunological products for animal health applications. Lipid Sciences will receive
This two-year Phase II grant, awarded through the Small Business Innovation Research (SBIR) program of the National Science Foundation, will support studies focused on the synthesis and testing
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.